Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering
KIRKLAND, Wash., March 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the pricing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share.
Kestra Medical Technologies aims to raise $150M in IPO
Kirkland, Wash.-based Kestra Medical Technologies is aiming to raise about $150 million in its initial public offering, pricing shares between $14 and $16 on the Nasdaq, according to a new regulatory filing.
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering
KIRKLAND, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the launch of its initial public offering of 10,000,000 common shares.
Kestra Medical Files For IPO On Substantial Operating Losses
Kestra Medical Technologies, Ltd. is experiencing strong revenue growth but faces high operating losses and significant cash burn. The firm markets a wearable cardiac defibrillator, ASSURE WCD, with a lease business model, showing promising efficacy but dependent on reimbursement policies. The global cardiac arrest treatment market is projected to grow significantly, presenting opportunities for Kestra despite competition and regulatory risks.
